Chemeca Drugs Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 7.61 Cr
as on 18-07-2024
- Company Age 21 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 15.24 Cr
as on 18-07-2024
- Revenue -3.15%
(FY 2023)
- Profit 16.02%
(FY 2023)
- Ebitda 9.38%
(FY 2023)
- Net Worth -29.98%
(FY 2023)
- Total Assets -11.09%
(FY 2023)
About Chemeca Drugs
The Corporate was formerly known as Vegesna Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 7.61 Cr.
The company has closed loans amounting to ₹15.24 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Alla Reddy, Pailla Reddy, Venkata Pallempalli, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239AP2003PTC041849
- Company No.
041849
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Chemeca Drugs Private Limited offer?
Chemeca Drugs Private Limited offers a wide range of products and services, including Industrial Chemicals, API Intermediate, Pharmaceutical Intermediates, API (Active Pharmaceutical Ingredients), Pharmaceutical Services.
Who are the key members and board of directors at Chemeca Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pailla Reddy  | Managing Director | 04-Oct-2017 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alla Reddy  | Director | 14-Sep-2017 | Current |
| Venkata Pallempalli | Director | 27-Jul-2018 | Current |
| Saketh Pailla | Director | 02-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of Chemeca Drugs.
Chemeca Drugs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.15% decrease. The company also saw a substantial improvement in profitability, with a 16.02% increase in profit. The company's net worth observed a substantial decline by a decrease of 29.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemeca Drugs?
In 2021, Chemeca Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Smart Agro Industries Corporation Private LimitedActive 15 years 10 monthsSaketh Pailla is a mutual person
Smart Agro Food Park Private LimitedActive 10 years 6 monthsPailla Reddy and Saketh Pailla are mutual person
Sciegen Pharmaceuticals India Private LimitedActive 11 years 10 monthsAlla Reddy, Pailla Reddy and 2 more are mutual person
Bactolac Nutraceuticals Private LimitedActive 1 year 5 monthsAlla Reddy, Pailla Reddy and 1 more are mutual person
- Azura Plastics Private LimitedActive 1 year 5 months
Alla Reddy, Pailla Reddy and 1 more are mutual person
- Chemart Pharma Private LimitedActive 4 years 4 months
Alla Reddy and Saketh Pailla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Reliance Capital Ltd Creation Date: 31 Mar 2014 | ₹5.13 M | Satisfied |
Reliance Capital Ltd Creation Date: 30 Jun 2013 | ₹6.28 M | Satisfied |
Axis Bank Limited Creation Date: 13 Oct 2006 | ₹12.30 Cr | Satisfied |
How Many Employees Work at Chemeca Drugs?
Chemeca Drugs has a workforce of 172 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemeca Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemeca Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
